Evidence map›Paper›PMID 36557385›Full record

ArticleMicromachines2022

Dual-Function Metasurface for Tunable Selective Absorption.

Jingyu Zhang, Hanbing Yan, Xiaoqing Yang, Haohui Lyu

Abstract read
In one paragraph

Article in Micromachines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jingyu ZhangSchool of Electronics and Information Engineering, Sichuan University, Chengdu 610065, China.
Hanbing YanSchool of Control Engineering, Chengdu University of Information Technology, Chengdu 610225, China.
Xiaoqing YangSchool of Electronics and Information Engineering, Sichuan University, Chengdu 610065, China.
Haohui LyuSchool of Control Engineering, Chengdu University of Information Technology, Chengdu 610225, China.

Funding

High tech ship research project of ministry of industry and information technology JJT【2019】No.357 of MITKey Special Project for Introduced Talents Team of Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou) GML2019ZD0502Open Project of Key Laboratory of Testing Technology for Manufacturing Process (Southwest University of Science and Technology) 18kfzk03
6 · The paper itself

Abstract

Metamaterials have become a powerful technique in interdisciplinary research, especially in the field of designing terahertz devices. In this paper, two pairs of different structural units of aluminum-polymer composite metamaterials (APCM) for tunable selectivity are designed. One is designed to achieve high-contrast near-field imaging of linear polarized waves, the other is designed to achieve high-contrast near-field imaging of circularly polarized waves, which means the structural units have very large circular dichroisms. After theoretical design and simulation optimization, it can be found that the contrast of near-field imaging can be effectively controlled by using vanadium oxide (VO2) to fill the open gap of the structure. When the conductivity of VO2 is 200 S/m, both the reflection difference under linear polarization excitation and the reflection difference under the excitation of the circularly polarized wave are at the maximum. The former has a modulation depth of 0.8, and the latter has a modulation depth of 0.55. This work shows excellent tunable selective absorption ability, which will promote the application of metamaterials in terahertz absorber, such as biomedical, non-destructive testing, security inspection, wireless communication and so on.

Indexed as

metasurfaceterahertztunable selective absorption

Identifiers

PMID36557385
PMCPMC9783640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.